$21.45
-0.48-2.19%
At Close: -
$21.45
00.00%
After Hours: 5:06 PM EDT
15 minutes delayed
Arcturus Therapeutics
ARCTNASDAQ
Arcturus Therapeutics (NASDAQ:ARCT) Stock, Insider Trading Activity
Arcturus Therapeutics: Insider buying and selling updated today.
Institutional Shares Held
24.800M
Institutional Percentage Held
92.1%
| Jun 14, 2024 | ANDY SASSINE | CHIEF FINANCIAL OFFICER | -50K | $32.03 | -$1.60M | SELL | -18.48% | 220.526K | Jun 12 | View |
| Jun 07, 2024 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -114 | $45.00 | -$5.13K | SELL | -0.03% | 447.334K | Jun 05 | View |
| Jun 04, 2024 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -26K | $40.01 | -$1.04M | SELL | -5.49% | 447.448K | Jun 03 | View |
| Mar 27, 2024 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -17.435K | $35.02 | -$610.57K | SELL | -3.55% | 473.448K | Mar 25 | View |
| Mar 21, 2024 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -8.565K | $35.01 | -$299.84K | SELL | -1.71% | 490.883K | Mar 19 | View |
| Nov 03, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $18.72 | -$93.60K | SELL | -0.99% | 499.448K | Nov 01 | View |
| Oct 04, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $25.61 | -$128.06K | SELL | -0.98% | 504.448K | Oct 02 | View |
| Sep 05, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $31.45 | -$157.26K | SELL | -0.97% | 509.448K | Sep 01 | View |
| Aug 03, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $34.91 | -$174.55K | SELL | -0.96% | 514.448K | Aug 01 | View |
| Jul 18, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -25K | $35.01 | -$875.25K | SELL | -4.59% | 519.448K | Jul 14 | View |
| Jul 18, 2023 | Keith Kummerfeld | SEE REMARKS | 0 | $21.98 | -$181.47K | SELL-OPTIONS | 0.00% | 950 | Jul 14 | View |
| Jul 07, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $28.75 | -$143.75K | SELL | -0.91% | 544.448K | Jul 03 | View |
| Jun 05, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $27.16 | -$135.80K | SELL | -0.90% | 549.448K | Jun 01 | View |
| May 12, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -25K | $30.08 | -$751.90K | SELL | -4.31% | 554.448K | May 10 - May 11 | View |
| May 03, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $25.93 | -$129.65K | SELL | -0.86% | 579.448K | May 01 | View |
| Apr 19, 2023 | Keith Kummerfeld | SEE REMARKS | 0 | $18.57 | -$133.95K | SELL-OPTIONS | 0.00% | 950 | Apr 18 | View |
| Apr 05, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $25.38 | -$126.90K | SELL | -0.85% | 584.448K | Apr 03 | View |
| Mar 08, 2023 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -5K | $16.07 | -$80.35K | SELL | -0.84% | 589.448K | Mar 06 | View |
| Dec 19, 2022 | Magda Marquet | DIRECTOR | 2.222K | $18.00 | $40.00K | BUY | 9.78% | 24.942K | Dec 15 | View |
| Nov 28, 2022 | Joseph Payne | PRESIDENT AND CEO | 5K | $16.51 | $82.55K | BUY | 0.34% | 1.480097M | Nov 23 | View |
| Jan 06, 2022 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -8.1K | $40.00 | -$324.00K | SELL | -1.34% | 594.448K | Jan 04 | View |
| Dec 20, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -3.633K | $40.00 | -$145.33K | SELL | -0.60% | 602.548K | Dec 16 | View |
| Dec 10, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -6.367K | $40.00 | -$254.68K | SELL | -1.04% | 606.181K | Dec 08 | View |
| Nov 03, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $44.41 | -$444.10K | SELL | -1.61% | 612.548K | Nov 01 | View |
| Oct 04, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $44.36 | -$443.60K | SELL | -1.58% | 622.548K | Oct 01 | View |
| Sep 02, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $55.86 | -$558.60K | SELL | -1.56% | 632.548K | Sep 01 | View |
| Aug 12, 2021 | Ultragenyx Pharmaceutical Inc | DIRECTOR | -800K | $54.54 | -$43.63M | SELL | -36.36% | 1.4M | Aug 10 - Aug 11 | View |
| Aug 05, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $40.07 | -$400.70K | SELL | -1.53% | 642.548K | Aug 03 | View |
| Apr 05, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $42.95 | -$429.50K | SELL | -1.51% | 652.548K | Apr 01 | View |
| Mar 03, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $54.23 | -$542.30K | SELL | -1.49% | 662.548K | Mar 01 | View |
| Feb 03, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $75.31 | -$753.10K | SELL | -1.47% | 672.548K | Feb 01 | View |
| Jan 05, 2021 | Pad Chivukula | CHIEF SCIENTIFIC OFFICER & COO | -10K | $46.40 | -$464.00K | SELL | -1.44% | 682.548K | Jan 04 | View |
| Dec 10, 2020 | Ultragenyx Pharmaceutical Inc | — | -800K | $100.81 | -$80.65M | SELL | -26.67% | 2.2M | Dec 08 - Dec 09 | View |
| Dec 03, 2020 | Pad Chivukula | — | -10K | $96.19 | -$961.90K | SELL | -1.42% | 692.548K | Dec 01 | View |
| Nov 03, 2020 | Pad Chivukula | — | -10K | $55.28 | -$552.80K | SELL | -1.40% | 702.548K | Nov 02 | View |
| Oct 02, 2020 | Pad Chivukula | — | -10K | $42.83 | -$428.30K | SELL | -1.38% | 712.548K | Oct 01 | View |
| Sep 04, 2020 | Pad Chivukula | — | -10K | $45.16 | -$451.60K | SELL | -1.37% | 722.548K | Sep 03 | View |
| Jun 12, 2020 | Keith Kummerfeld | — | 450 | $33.33 | $15.00K | PURCHASE | 90.00% | 950 | Jun 12 | View |
| Jun 10, 2020 | Joseph Payne | — | 1K | $31.69 | $31.69K | PURCHASE | 0.07% | 1.475097M | Jun 10 | View |
| Jun 10, 2020 | ANDY SASSINE | — | 5K | $29.74 | $148.70K | PURCHASE | 1.86% | 273.245K | Jun 10 | View |
| Dec 09, 2019 | ANDY SASSINE | CHIEF FINANCIAL OFFICER | 5.649K | $9.73 | $54.96K | BUY | 2.15% | 268.245K | Dec 05 | View |
| Dec 05, 2019 | ANDY SASSINE | CHIEF FINANCIAL OFFICER | 10K | $10.00 | $100.00K | BUY | 4.04% | 257.596K | Dec 03 | View |
| Sep 17, 2019 | Magda Marquet | DIRECTOR | 2.3K | $10.58 | $24.33K | BUY | 11.26% | 22.72K | Sep 13 | View |
| Sep 12, 2019 | Keith Kummerfeld | SEE REMARKS | 500 | $10.69 | $5.35K | BUY | ∞ | 500 | Sep 12 | View |
| Aug 30, 2019 | Joseph Payne | PRESIDENT AND CEO | 5K | $11.22 | $56.10K | BUY | 0.34% | 1.474097M | Aug 29 | View |
| Aug 26, 2019 | ANDY SASSINE | CHIEF FINANCIAL OFFICER | 10K | $10.90 | $109.00K | BUY | 4.21% | 247.596K | Aug 23 | View |
| Aug 21, 2019 | PETER FARRELL | DIRECTOR | 9.113K | $10.94 | $99.67K | BUY | 10.54% | 95.565K | Aug 19 - Aug 20 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.